Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples